Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, S. A.
Right arrow Articles by Milner, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, S. A.
Right arrow Articles by Milner, J. A.
© 2006 American Society for Nutrition J. Nutr. 136:852S-854S, March 2006


Supplement: Significance of Garlic and Its Constituents in Cancer and Cardiovascular Disease

Allyl Sulfur Compounds from Garlic Modulate Aberrant Crypt Formation1,2

Sharon A. Ross*,3, John W. Finley{dagger} and John A. Milner*

* Nutritional Sciences Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Rockville, MD 20892-7328 and {dagger} A. M. Todd, Inc., Montgomeryville, PA 18936

3 To whom correspondence should be addressed: rosssha{at}mail.nih.gov.


    ABSTRACT
 TOP
 ABSTRACT
 DISCUSSION
 LITERATURE CITED
 
The health benefits of garlic, including inhibition of carcinogenesis, are supported by several epidemiologic and laboratory findings. Garlic's sulfur components have been reported to suppress experimentally induced tumor incidence in several organs, including the colon. Studies in humans also suggest that dietary garlic constituents reduce the risk of colorectal adenomatous polyps, which are considered precursors to colon cancer. Aberrant crypt foci (ACF) are proposed to be early preneoplastic lesions of adenoma-carcinoma in humans and chemically induced colon cancer in rodents. In preclinical studies, both water- and lipid-soluble allyl sulfur compounds arising from processed garlic inhibited ACF. The response to these allyl sulfur compounds appears to depend on several factors, including the speciation, quantity, and duration provided.


KEY WORDS: • Aberrant crypt foci • colorectal cancer • garlic • allyl sulfur compounds

Colorectal cancer remains an important global health concern, because it has a high mortality rate and its prevalence is increasing. It is the 3rd most prevalent cancer and the 3rd leading cause of cancer deaths in the United States (1). Despite developments in surgical techniques and chemotherapy, there has been only a modest improvement in survival for patients presenting with advanced neoplasms. Effective preventive measures are paramount to minimize morbidity and mortality from this disease; in fact, evidence suggests that diet and bioactive food components are likely to affect the development of colorectal cancer.

Epidemiologic studies found that increased intake of garlic, and/or its active constituents, is associated with reduced colorectal cancer (24). For example, results from the Iowa Women's Health Study, a prospective cohort study, found that the strongest association among fruits and vegetables for reduction of colon-cancer risk was for garlic consumption, with an ~50% lower risk of distal colon cancer associated with high consumption (3). Additionally, a meta-analysis of data from 7 epidemiologic studies found an inverse association between raw and cooked garlic consumption and colorectal cancer risk (4). Although the mean intake of garlic per person in the United States is approximately ≤0.6 g/wk (3), intakes in areas of China may be as high as 20 g/d (5).

Garlic has long been asserted to possess medicinal properties. Part of its distinction may be associated with sulfur, which can comprise ~1% of its dry weight (6). Among the contributors of sulfur in garlic are the allyl sulfur components [e.g., diallyl disulfide (DADS),4 and S-allylcysteine (SAC)], which have been studied extensively for their cancer prevention capacity.

    Experimental colon cancer. Colorectal cancer is thought to develop through a series of steps involving genetic and morphological alterations. Numerous studies have focused on the significance of alterations in select crypts as early events in experimental colon carcinogenesis. Aberrant crypt foci (ACF) are early appearing lesions recognized in the colonic surface of rats treated with colon-specific carcinogens such as azoxymethane (AOM) and 1,2-dimethylhydrazine (DMH) (7). The number of ACF increases with time after the carcinogen treatment; they have an increased proliferative activity, and some ACF reveal histological dysplasia (8). ACF similar to those in rodents were also reported in the colonic mucosa in humans (9). Therefore, ACF are regarded as putative preneoplastic lesions for colon cancers and have been used to evaluate potential bioactive food components against colon carcinogenesis (7,10). The potency of an agent (dietary or chemopreventive) to reduce the number of ACF and to reduce the incidence of tumors in the colon of rats is significantly correlated (7). Nevertheless, some inconsistencies occur between tumor development and ACF lesions, suggesting the need for further characterization of the lesion (10). Recent studies have focused on identifying specific histological (i.e., mucin-depleted foci) or molecular (i.e., ß-catenin accumulated crypts) changes to enhance the predictive value of ACF for cancer outcome (11).

Preclinical studies with C57BL/6J mice revealed that the lipid-soluble garlic constituent diallyl sulfide (DAS) given orally before DMH injection significantly reduced the incidence and frequency of colorectal adenocarcinoma (12). In another chemical-carcinogenesis study, the water-soluble garlic constituent SAC inhibited colonic tumors when given 3 h before DMH (13). These findings have encouraged additional research on the mechanism of action of garlic and its constituents in cancer protection. They also have enhanced interest in determining the importance of timing on the anticarcinogenic effect, that is, whether garlic is effective in inhibiting early, preneoplastic lesions.

    Protective effect of lipid-soluble allyl compounds in aberrant crypt models. When garlic cloves are disrupted, the enzyme allinase is released; it converts the allin to allicin, a transient compound that quickly rearranges into more stable compounds such as DAS, DADS, and diallyl trisulfide (14). These compounds are primary compounds in preparations containing "garlic oil," although the chemical composition of different preparations varies. Both DAS and DADS were examined for efficacy in inhibiting aberrant crypt formation (15,16). DAS was shown to significantly inhibit ACF in an AOM-induced rat colon model at 1 and 2 g/kg diet (15); DAS was provided 1 wk before injection of the carcinogen and continued throughout the study. These investigators found DAS (79 and 43% of control for DAS when provided at 1 and 2 g/kg diet, respectively) to be less potent than nonsteroidal anti-inflammatory agents (64 and 49% of control for ibuprofen at 0.2 and 0.4 g/kg diet) in inhibiting ACF. The effect of DADS on AOM-induced ACF in rat colon during the postinitiation phase (that is provided in the diet during the last 4 wk of an 8-wk assay) was mixed. In this experiment, DADS at 0.1 g/kg diet, but not at 0.2 g/kg diet, significantly inhibiting ACF (77% of control) (16). Unfortunately, DADS was not examined for activity during the initiation phase by these investigators.

As described above, many studies testing the effect of garlic constituents on aberrant crypt formation have generally shown beneficial effects. However, one study observed an increase in the number of ACF in Fischer 344 rats when DAS (150 or 50 mg/kg) was given by gavage before carcinogen treatment (AOM provided at 20 mg/kg) (17). In that study, rats were killed 10 wk after the last injection of AOM. Rats pretreated with the high-dose gavage administration of DAS exhibited a significant increase in the number of ACF in the distal colon compared with rats administered AOM alone. These investigators also hypothesized that DAS may alter the disposition of AOM or its metabolites in vivo because the compound was shown to modulate phase I and II enzyme activities. An earlier study found that rats administered 1 g/kg DAS in the diet 1 wk before AOM exposure (2 s.c. injections, 15 mg/kg each, 1 wk apart) developed 10% more ACF than colons from the AOM-treated rats fed control diets; the results, however, were not significant (18). The results of these negative findings compared with the other studies might be explained by the large doses of DAS administered, as well as the route and timing of administration of the organosulfur compound.

    Protective effect of water-soluble allyl compounds on aberrant crypt foci. SAC is a naturally occurring, water-soluble organosulfur compound derived from garlic, which has been examined for its ability to inhibit aberrant crypt formation in the rat colon. Interestingly, SAC incorporated into the experimental diet (at either 0.125 or 0.25 g/kg diet) of rats significantly decreased the number of ACF by 33 and 54%, respectively, when given during the initiation period (DMH administered i.p. 1 time/wk for 2 wk at 25 mg/kg), but had no effect when given during tumor promotion (19). The anti-initiation property of SAC was suggested to relate to its ability to increase glutathione-S-transferase (GST) and therefore enhance carcinogen detoxification.

SAC was also reported to block AOM-induced tumorigenesis. Adding SAC to the diet at concentrations of 0.125 and 0.25 g/kg reduced aberrant crypt formation by 68 and 46% of control, respectively, when provided during the initiation phase of carcinogenesis (16).

Similar to DMH, the response to SAC did not differ from control when tested in the AOM postinitiation phase. It was previously suggested by these investigators that the effect of SAC during the initiation phase might be due to stimulation of detoxifying enzymes (e.g., GST) and/or inhibition of metabolic activating enzymes (e.g., cytochrome P450), thereby modulating the fate of the carcinogen metabolite that damages DNA (13).

Another laboratory investigated the ability of aqueous solutions of crushed garlic to inhibit ACF (2022). In studies by Sengupta et al. (20), Sprague-Dawley rats (4–5 wk old) were injected with AOM (3 weekly s.c. injections of 15 mg/kg birth weight) and orally administered a 2% aqueous suspension (wt:v) of garlic starting on d 1 of AOM injection. The garlic suspension was prepared by grinding dehusked cloves of garlic using a mortar and pestle and diluting the resulting paste with water to make a 2% aqueous suspension (wt:v); it was estimated that the rats received 20 mg garlic/d; 12 wk after the first AOM injection, colons were assessed for ACF and compared with the carcinogen control group. The aqueous garlic solution reduced ACF by ~32% compared with control fed rats. The investigators replicated these findings and reported that the same dose of garlic inhibited ACF by 45% (21), and in a third study, a 2.5% aqueous suspension (wt:v) of garlic inhibited ACF by 42% (22). Additional findings from this laboratory suggested that the anticarcinogenic potential of the aqueous garlic suspension may be due to modulation of phase II enzymes (e.g., GST) as well as interference with apoptotic and/or proliferative pathways in the colon.

    Evaluation of the speciation of allyl compounds on aberrant crypt foci. We recently compared the effect of allyl sulfur compound speciation on ACF (23). Rats were fed a semipurified, casein-based diet with or without 57 or 570 µmol/kg SAC, DADS, or S-allylmercaptocysteine (SAMC), another water-soluble organosulfur constituent found in garlic. Rats were fed their diets for 3 wk before treatment with DMH (25 mg/kg i.p. each week for 2 wk). All rats consumed their assigned diets for 13 wk before determination of ACF and aberrant crypt number (AC). All treatments, except 57 µmol/kg SAC, significantly lowered ACF compared with controls. The AC were significantly reduced by DADS and SAMC at both concentrations tested. Although a diminished body weight may be associated with decreased ACF in rats fed 570 µmol/kg DADS or SAMC, it was not changed by lower exposures and therefore did not account for the reduced aberrations. This study reveals that all allyl sulfur compounds are not equivalent in retarding early preneoplastic markers for colon cancer and also suggests that disulfides are more effective in suppressing ACF and AC. Moreover, this study demonstrates that increasing the exposure 10-fold did not lead to further massive suppression in ACF, suggesting a saturation point for their target. In this study, the allyl sulfurs examined did not greatly influence liver GST activity, suggesting that a shift in the activity of this liver enzyme did not relate to reduced ACF or AC.


    DISCUSSION
 TOP
 ABSTRACT
 DISCUSSION
 LITERATURE CITED
 
Several studies examined the effect of lipid- and water-soluble allyl sulfur compounds on the inhibition of ACF in rodents. The studies differed by allyl sulfur speciation and dose, mode of administration, as well as duration of exposure to the garlic constituent. Most preclinical studies found garlic to be protective when administered during the initiation phase of ACF-induction. Although fewer in number, postinitiation phase studies suggest that only DADS is effective, but this response appears to be highly dependent on the quantity provided. In addition to modulating ACF, many of the studies found that the allyl sulfur compound affected either Phase I or Phase II enzyme activity, thereby leading us to hypothesize that the reductions in ACF are related to changes in carcinogen metabolism. But again, these changes appear to be highly dependent on the quantity of allyl sulfur provided. The transcription factor Nrf2, which binds to the antioxidant response element (ARE) found in the upstream regulatory region of many phase II genes, is essential for the induction of these enzymes (24).

Thus, it is intriguing to speculate that some of the properties of allyl sulfur compounds from garlic may be mediated by Nrf2-ARE promoter interaction with consequent regulation of key phase II enzymes. The recent finding that disulfide garlic constituents (DADS, SAMC) were more potent in the ACF model than the single sulfide compounds (SAC) implicates additional pathways, such as modulation of thiol group biology, in the response to garlic constituents.

Although a systematic analysis has not been performed, many of the garlic compounds tested in the aberrant crypt model (i.e., DAS, SAC, and DADS) were also shown to inhibit chemical carcinogenesis of the colon in rodent models.

In summary, it is clear from several lines of evidence that allyl sulfur compounds from garlic likely influence colorectal cancer at various points in the carcinogenesis pathway (Fig. 1). The ACF assay is not only less expensive and time-consuming than tumor-producing studies, but it also should allow the elucidation of the colon carcinogenic process by exploring the molecular and morphological changes that occur at a precancerous stage.


Figure 1
View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 1  Garlic influences multiple phases of colon cancer. The allyl sulfur components from garlic were shown to influence several phases of the colorectal carcinogenesis pathway, including inhibition of preneoplastic lesions.

 
Future investigations to elucidate the mechanism of action of allyl sulfur compounds, including responses to differences in speciation, quantity, and duration of exposure in early-stage colon carcinogenesis are encouraged. Furthermore, clinical pilot studies to examine the effect of allyl sulfur compounds from garlic on ACF in humans are now warranted.


    FOOTNOTES
 
1 Published in a supplement to The Journal of Nutrition. Presented at the symposium "Significance of Garlic and Its Constituents in Cancer and Cardiovascular Disease" held April 9–11, 2005 at Georgetown University, Washington, DC. The symposium was sponsored by Strang Cancer Prevention Center, affiliated with Weill Medical College of Cornell University, and Harbor-UCLA Medical Center, and co-sponsored by American Botanical Council, American Institute for Cancer Research, American Society for Nutrition, Life Extension Foundation, General Nutrition Centers, National Nutritional Foods Association, Society of Atherosclerosis Imaging, Susan Samueli Center for Integrative Medicine at the University of California, Irvine. The symposium was supported by Alan James Group, LLC, Agencias Motta, S.A., Antistress AG, Armal, Birger Ledin AB, Ecolandia Internacional, Essential Sterolin Products (PTY) Ltd., Grand Quality LLC, IC Vietnam, Intervec Ltd., Jenn Health, Kernpharm BV, Laboratori Mizar SAS, Magna Trade, Manavita B.V.B.A., MaxiPharm A/S, Nature's Farm, Naturkost S. Rui a.s., Nichea Company Limited, Nutra-Life Health & Fitness Ltd., Oy Valioravinto Ab, Panax, PT. Nutriprima Jayasakti, Purity Life Health Products Limited, Quest Vitamins, Ltd., Sabinco S.A., The AIM Companies, Valosun Ltd., Wakunaga of America Co. Ltd., and Wakunaga Pharmaceutical Co., Ltd. Guest editors for the supplement publication were Richard Rivlin, Matthew Budoff, and Harunobu Amagase. Guest Editor Disclosure: R. Rivlin has been awarded research grants from Wakunaga of America, Ltd. and received an honorarium for serving as co-chair of the conference; M. Budoff has been awarded research grants from Wakunaga of America, Ltd. and received an honorarium for serving as co-chair of the conference; and Harunobu Amagase is employed by Wakunaga of America, Ltd. Back

2 Author disclosure: No relationships to disclose. Back

4 Abbreviations used: AC, aberrant crypt number; ACF, aberrant crypt foci; AOM, azoxymethane; ARE, antioxidant response element; DADS, diallyl disulfide; DAS, diallyl sulfide; DMH, 1,2-dimethylhydrazine; GST, glutathione-S-transferase; SAC, S-allylcysteine; SAMC, S-allylmercaptocysteine. Back


    LITERATURE CITED
 TOP
 ABSTRACT
 DISCUSSION
 LITERATURE CITED
 

1. Jemal A, Clegg LX, Ward E, Ries LAG, Wu X., Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004;101:3–27.[Medline]

2. Khanum F, Anilakumar KR, Viswanathan KR. Anticarcinogenic properties of garlic: a review. Crit Rev Food Sci Nutr. 2004;44:479–88.[Medline]

3. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol. 1994;139:1–15.[Abstract/Free Full Text]

4. Fleischauer AT, Poole C, Arab L. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr. 2000;72:1047–52.[Abstract/Free Full Text]

5. Mei X, Wang ML, Pan XY. Garlic and gastric cancer. I. The influence of garlic on the level of nitrate and nitrite in gastric juice. Acta Nutr Sin. 1982;4:53–6.

6. Fenwick GR, Hanley AB. The genus Allium. Part 2. Crit Rev Food Sci Nutr. 1985;22:273–377.[Medline]

7. Corpet DE, Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer. 2002;43:1–21.[Medline]

8. Bird R. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93:55–71.[Medline]

9. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.[Abstract/Free Full Text]

10. Wijnands MV, van Erk MJ, Doornbos RP, Krul CA, Woutersen RA. Do aberrant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours. Food Chem Toxicol. 2004;42:1629–39.[Medline]

11. Mori H, Hata K, Yamada Y, Kuno T, Hara A. Significance and role of early-lesions in experimental colorectal carcinogenesis. Chem Biol Interact. 2005;155:1–9.[Medline]

12. Wargovich MJ. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis. 1987;8:487–9.[Abstract/Free Full Text]

13. Sumiyoshi H, Wargovich MJ. Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res. 1990;50:5084–7.[Abstract/Free Full Text]

14. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components. J Nutr. 2001;131:955S–62.[Abstract/Free Full Text]

15. Wargovich MJ, Chen CD, Jimenez A, Steele VE, Velasco M, Stephens LC, Price R, Gray K, Kelloff GJ. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev. 1996;5:355–60.[Abstract/Free Full Text]

16. Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, Price R, Gray K, Kelloff GJ. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis. 2000;21:1149–55.[Abstract/Free Full Text]

17. Delker DA, Papanikolaou A, Suhr YJ, Rosenberg DW. Diallyl sulfide enhances azoxymethane-induced preneoplasia in Fischer 344 rat colon. Chem Biol Interact. 2000;124:149–60.[Medline]

18. Pereira MA, Khoury MD. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett. 1991;61:27–33.[Medline]

19. Hatono S, Jimenez A, Wargovich MJ. Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis. 1996;17:1041–4.[Abstract/Free Full Text]

20. Sengupta A, Ghosh S, Das S. Tomato and garlic can modulate azoxymethane-induced colon carcinogenesis in rats. Eur J Cancer Prev. 2003;12:195–200.[Medline]

21. Sengupta A, Ghosh S, Das S. Modulatory influence of garlic and tomato on cyclooxygenase-2 activity, cell proliferation and apoptosis during azoxymethane induced colon carcinogenesis in rat. Cancer Lett. 2004;208:127–36.[Medline]

22. Sengupta A, Ghosh S, Bhattacharjee S, Das S. Indian food ingredients and cancer prevention - an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pac J Cancer Prev. 2004;5:126–32.[Medline]

23. Ross SA, Finley JW, Leary P, Gregoire B, Milner J. Speciation effects of allyl sulfur compounds on aberrant crypt formation [abstract]. FASEB J. 2005;19(4):A72.13.

24. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol. 2002;22:2883–92.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
CarcinogenesisHome page
H. Nian, B. Delage, J. T. Pinto, and R. H. Dashwood
Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
Carcinogenesis, September 1, 2008; 29(9): 1816 - 1824.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Hosono, T. Hosono-Fukao, K. Inada, R. Tanaka, H. Yamada, Y. Iitsuka, T. Seki, I. Hasegawa, and T. Ariga
Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells
Carcinogenesis, July 1, 2008; 29(7): 1400 - 1406.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. N. T. Ngo, D. B. Williams, L. Cobiac, and R. J. Head
Does Garlic Reduce Risk of Colorectal Cancer? A Systematic Review
J. Nutr., October 1, 2007; 137(10): 2264 - 2269.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. D. Fisher, L. M. Augustine, J. M. Maher, D. M. Nelson, A. L. Slitt, C. D. Klaassen, L. D. Lehman-McKeeman, and N. J. Cherrington
Induction of Drug-Metabolizing Enzymes by Garlic and Allyl Sulfide Compounds via Activation of Constitutive Androstane Receptor and Nuclear Factor E2-Related Factor 2
Drug Metab. Dispos., June 1, 2007; 35(6): 995 - 1000.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, S. A.
Right arrow Articles by Milner, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, S. A.
Right arrow Articles by Milner, J. A.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2006 by American Society for Nutrition